INTRODUCTION: Tendons are vulnerable to various types of acute or chronic injures. Different methods have been investigated to achieve better healing. Phenytoin is a drug which could stimulate fi broblasts to produce collagen. This experimental study was performed to assess the effect of phenytoin on tendon healing in a rat model of tendon rupture. METHODS: Thirty healthy rats were divided into 3 groups, 1) Sham group; 2) Tendon rupture; 3) Tendon rupture+phenytoin (100 mg/kg intraperitoneally) for 21 days. On 21st day after tendon injury, the rats were anesthetized and tendon tissue was sampled for studying by light and electron microscopy. RESULTS: Qualitative and quantitative microscopic comparisons of the repair tissues of both groups were made on the 21st day. The results obtained from light and electron microscopy studies showed that tendon tissue healing was signifi cantly better in phenytoin group compared to the control group (p < 0.05). CONCLUSIONS: Systemic administration of phenytoin may have a positive effect on tendon healing by increasing fi broblast quantity, fi brillar collagen synthesis, vascularity, and suppressing infl ammation (Tab. 2, Ref. 25). Text in PDF www.elis.sk.
Introduction
Achilles tendon rupture is a relatively common injury resulting in a prolonged healing process and signifi cant disability. The injury associated with Achilles tendon rupture is sometimes a result of athletic activity and middle-aged individuals are particularly prone to the injury (1) .
Tendons are composed of parallel bundles of collagen fi bers (primarily type I) and rows of fi broblasts situated between these bundles. The most important function of the type I collagen, the main functional component of tendons, is to provide resistance to force, tension and stretch (2) . The Achilles tendon, formed by the merging of gastrocnemius and soleus tendons, is the thickest and strongest tendon in the human body. Achilles tendon rupture is still a challenging problem, and the peak annual incidence of Achilles tendon rupture has been reported as 18 per 100,000 (3) . The course of the tendon healing depends on several factors such as age, nutrition, systemic diseases, hormones, infections and vitamins (4) .
The tendon is a hypocellular and hypovascular tissue that heals slowly and usually repairs through scar formation. The healing process may last for several months and even years, and injured tendons never recover the functional properties of healthy and normal tendons (5) . In an attempt to compensate for the ineffi cient repair process, researchers and clinicians have developed and tested various treatment strategies including nonsteroidal anti-infl ammatory drugs (NSAIDs), tissue engineering, mobilization, mechanical loading, and other physical modalities such as ultrasound, extracorporeal shock-wave therapy and electrical stimulation (5) .
Phenytoin (sodium diphenylhydantoin) is a well-known antiepileptic medication that has been used clinically since 1938. Phenytoin can stimulate responsive sub-populations of fi broblasts to synthesize increased amounts of collagen and glycosaminoglycans (6) and has been used in the healing of pressure sores, venous stasis, diabetic ulcers, traumatic wounds, and burns (7) . It has been postulated that phenytoin administration might possibly promote wound healing by increasing the collagen deposition in rat skin. Although exact tissue mechanisms of action of phenytoin are unknown, growth factors, especially vascular endothelial growth factor (VEGE) and basic fi broblast growth factor (BFGF), have been indicated as mediators for the neovascularization and collagen fi ber production by the fi broblasts; important steps for the wound healing (8) .
To the best of our knowledge, possible role of phenytoin in tendon healing process has not been hitherto investigated in the literature. Therefore, the aim of the present study was to evaluate the effect of phenytoin on tendon healing in a rat model of tendon rupture.
Methods

Animals
Thirty male Wistar rats (6-8 weeks, average body weight of 270 g) were randomly divided into 3 groups. In Group 1 (sham group), animals were anesthetized and posterior incision was performed on the skin, superior to the Achilles tendon. In Group 2 animals underwent anesthesia and Achilles tendon rupture. In Group 3, animals underwent tendon rupture and also received 100 mg/kg phenytoin intraperitoneally for 21 days (9) . The animals were kept and treated according to international guidelines for the care of laboratory animals.
Surgery protocol
Under general anesthesia, a posterior incision was made to expose the patellar tendon. The Achilles and plantaris tendons were stripped from the surrounding fascia. The Achilles tendon was transected fi ve millimeters proximal to its insertion to the calcaneus. The plantaris tendon was also transected to prevent internal splint effect. The Achilles tendon was repaired by using 6/0 ethilon monofi lament nylon sutures. The wound was closed with 3/0 ethilon monofi lament uninterrupted sutures (10) . The rats were allowed free cage movement immediately after surgery. At day 21 after injury, the rats were sacrifi ced. The Achilles tendons were harvested, washed in phosphate buffered saline (PBS), fi xed in buffered formalin, and then used to prepare 5-mm-thick histological sections for hematoxylin and eosin staining. Achilles tendons without injury were used as an ideal end point of tendon healing and control.
Light microscopy study
Tissue samples were fi xed in 10 % neutral buffered formalin overnight, and then dehydrated with alcohol. The fi xed tissue was processed, embedded in paraffi n, and sectioned at 3 micrometers. Finally, tissue sections were stained with haematoxylin and eosin. Fibroblast density, infl ammation, vascularity and collagen fi ber orientation were graded on a four-point grading system on the following scale: 0 (normal appearance), 1 (slightly abnormal appearance), 2 (moderately abnormal appearance), and 3 (markedly abnormal appearance) (11) . To investigate the collagen fi ber orientation, Masson-Trichrome stain was used. For each staining technique, two slides were prepared. The area of specimen showing the most advanced pathological changes was selected, and the worst possible results for each slide were used in this study. Slides were examined by the same pathologist, who was blinded to the study protocol, under light microscope (Olympus Bx50 Shinjuku, Monolith, Tokyo, Japan) (10) .
Electron microscopy preparation
For transmission electron microscopy, the tendon biopsies from rats of all three studied groups were cut into 1 mm x 1 mm and fi xed in 2 % glutaraldehyde in a 0.1 M phosphate buffer and postfi xed in 1 % aqueous osmium tetroxide. The pieces were then dehydrated through graded concentration of ethanol, and embedded in resin. One micron semi-thin sections were stained with tolidine blue. Ultra-thin sections from selected blocks were stained with uranyl acetate and lead citrate and observed in a LEO 906 type transmission electron microscope (Carl Zeiss, Oberkochen, Germany).
Statistical analysis
Data were presented as mean ± standard deviation (SD). Histological sum grades between the groups were analyzed using Mann-Whitney U test. Statistical analysis was performed with SPSS for windows version 16.0 (SPSS Inc, Chicago, IL, USA). A p value ≤ 0.05 was considered statistically signifi cant.
Results
Light microscopy results
Data showed that fi broblast density was higher in both tendon injury and tendon injury + phenytoin groups compared to the sham group (p = 0.008 vs p = 0.0001). On the other hand, the fi broblast density was signifi cantly higher in tendon injury + phenytoin group than tendon injury group (p = 0.002) (Tabs 1 and 2).
Infl ammatory score was signifi cantly higher in the tendon injury group than in the sham group (p = 0.001) and tendon injury + phenytoin group (p = 0.009). However, there was no statistical difference in infl ammatory score between the sham and tendon injury + phenytoin groups (p = 0.156) (Tabs 1 and 2) .
The mean histological grade of collagen fi ber abnormality was signifi cantly greater in tendon injury group than sham group (p = 0.005) and tendon injury + phenytoin group (p = 0.001). In ad-
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Tab. 1. Distribution of tendon injury grades.
dition, the mean histological grade of collagen fi ber abnormality was signifi cantly higher in tendon injury + phenytoin group than sham group (p = 0.002) (Tabs 1 and 2). Data showed that vasculogenesis was signifi cantly higher in tendon injury + phenytoin group compared to tendon injury group (p = 0.001). Moreover, vasculogenesis was signifi cantly higher in both tendon injury and tendon injury+ phenytoin groups compared to sham group (p = 0.005 and p = 0.002, respectively) (Tabs 1 and 2).
Electron microscopy results
We used the fi brillar collagen formation, collagen arrangement, cellular function and level of cellular synthesis as histopathologic evaluation parameters. Histologically, collagen synthesis was better and more organized in phenytoin+tendon injury group compared to tendon injury group. Signifi cant differences were observed between phenytoin + tendon injury group and tendon injury group. There was marked mitochondrial degeneration and less fi brillar collagen synthesis in tendon injury group. A better healing was observed in phenytoin + tendon injury compared to tendon injury group (control).
Discussion
The fi ndings of the present study revealed that phenytoin treatment after tendon injury for a period of 21 days enhanced tendon healing, collagen synthesis and vascularity of the injured tendon. Furthermore, our data indicated that infl ammation grade was signifi cantly lower in the phenytoin group comparedto control group, implying anti-infl ammatory role of phenytoin. To the best of our knowledge, the present study is the fi rst investigation orchestrated to assess the effect of phenytoin on tendon healing in a rat model of tendon rupture. As gingival hyperplasia affects approximately 50% of patients on phenytoin as an anti-epileptic drug, possible therapeutic role of phenytoin in the wound healing has been deemed. Subsequently, a number of clinical trials have provided evidence of an increased rate of repair with reduced edema and infl ammation and enhanced formation of granulation tissue following the topical application of phenytoin to cutaneous wounds (11) .
Tendon healing occurs in three overlapping phases. In the initial infl ammatory phase, erythrocytes and infl ammatory cells, particularly neutrophils, enter the site of injury. In the fi rst 24 hours, monocytes and macrophages predominate, and phagocytosis of necrotic materials occurs. Vasoactive and chemotactic factors are released with increased vascular permeability, initiation of angiogenesis, stimulation of tenocyte proliferation, and recruitment of more infl ammatory cells. Tenocytes gradually migrate to the wound, and type III collagen synthesis is initiated. After a few days, the remodeling stage begins during which synthesis of type III collagen peaks, lasting for a few weeks. Water content and glycosaminoglycan concentrations remain high during this stage (12) . After approximately 6 weeks, the modeling stage commences and the healing tissue is resized and reshaped. Large quantities of type I collagen are synthesized during early modeling stage. After 10 weeks, the maturation stage occurs, with gradual change of fi brous tissue to scar-like tendon tissue over the course of one year (13) . The management of tendon injury is a challenge for physicians. Therefore, factors affecting the tendon healing are extremely signifi cant (14) .
The possible mechanism of action by which phenytoin promotes wound healing has been investigated. Various in vitro and clinical studies have indicated that phenytoin increases the proliferation of fi broblasts (15) , collagen deposition (16) , neovascularisation (17), and the granulation tissue formation (18) . In our investigation, phenytoin administration increased the fi broblast accumulation at the injury site; the fi broblast index was about 2.5 times higher in the phenytoin group comparedto the control group. Our data showed that collagen grade and collagen arrangement were higher in tendon injury + phenytoin group compared to tendon injury group. Moreover, phenytoin administration increased collagen density at the injury site. Increased collagen may be due to the effect of phenytoin on transcription rates of the collagen genes or posttranslational mRNA processing (19) . Phenytoin has also been reported to enhance the maturation of collagen in both normal skin and granulation tissue in rats, possibly by promoting collagen cross-linking (19) . Eisenberg et al determined that the increased collagenization with phenytoin treatment was due to the inhibition of collagenase (20) . Nevertheless, Bauer and colleagues found that phenytoin did not inhibit the enzyme directly, but decreased its synthesis and/or secretion (21) . Swamy et al reported that phenytoin, as wound healing agent, had potent growth factors inducing activity. The most interesting fi nding in their study was that phenytoin accelerated the autocrine and paracrine activities of growth factors by up-regulating the related receptors (22) . It has also been shown that phenytoin induces both latent TGFb and PDGF and also up-regulates the various matrix remodeling genes and receptors at the mRNA level in vitro, possibly implying its role in promoting angiogenesis, collagen synthesis and thus tendon repair (23) (24) (25) .
Conclusion
Phenytoin administration may enhance tendon healing by suppressing infl ammation, recruiting fi broblasts into the injury site, in- Values are given as mean ±standard deviation. Tendon healing was better in tendon injury+ phenytoin group compared to tendon injury group, and phenytoin administration signifi cantly accelerated the tendon healing in rats (fi broblast density (p = 0.002), infl ammatory score (0.009), collagen fi ber abnormality (0.001) and vasculogenesis (0.001)).
Tab. 2. Summary of the mean histological sum grade.
ducing vasculogenesis, collagen formation, collagen arrangement, cellular function and protecting mitochondria degeneration in ruptured tendon in rat. Regarding slow healing of tendon after injury, phenytoin may be a useful agent for accelerating the tendon healing process. Although our study demonstrates that the administration of phenytoin to rats leads to signifi cantly improved tendon healing, mechanism of action of phenytoin in this process still remains obscure. Nonetheless, these effects of phenytoin may be attributed to the growth factors. More investigations are required to further delineate the effects of phenytoin on the tendon-healing process.
